Nathan Johnson

CTO

Cannabisque, LLC

    Southbridge, Massachusetts, US

  Login to View Email
  Login to View Phone Number
  Login to View Website
Follow
Industry Role:
Login to Find Out


Specialty/Type:
Login to Find Out
Login to Find Out
Login to Find Out
Bio
Dr. Nathan T Johnson is a co-founder and CTO of Cannabisque, LLC. Previously, he has been part of the Laboratory of Systems Biology at Harvard Medical School, Breast Tumor Immunology Lab at Dana Farber Cancer Institute, Takeda, Chestnut Labs, Mouse and Rat Resource Centers in Columbia, MO, and Children’s Mercy Hospital. Dr. Nathan T Johnson is a hybrid of microbiology, molecular biology, and bioinformatic training across the USA. Over the past 15 years, Dr... (login for more professional bio)
Related News (Login for News Relating to Profile)
Login for news relating to profile
FEATURED MEMBER POSTS
Andrea Alms Video:  Money In Motion 142 - 2025 Whitehouse Stops All Communication With HHS, FDA, CDC
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 145 - Biotech IPO Market Forecast 2025
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 147 - Pediatric Healthcare Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 143 - 2024 Cancer Research Breakthroughs
- posted by: BrookDell Partners
Andrea Alms Video: Money In Motion 148 - Water Market
- posted by: BrookDell Partners
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.